Evidence map›Paper›PMID 28035196›Full record

ArticleGastroenterology & hepatology2016

Therapeutic Use of Cannabis in Inflammatory Bowel Disease.

Waseem Ahmed, Seymour Katz

Open access · greenAbstract read
PubMed Full text at PMC
In one paragraph

Article in Gastroenterology & hepatology, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 46 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
46citing papers in PubMed, 1 pooled it
5.8field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

46 citing papers in PubMed, 1 synthesis or guideline pooled it, 84 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Review
  4. International journal of molecular sciences · 2025
    Article
  5. Review
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Use of Complementary and Alternative Therapies in People with Inflammatory Bowel Disease.International journal of environmental research and public health · 2024
    Article
  13. Article
  14. Article
  15. Review
  16. Article
  17. Review
  18. A Survey of Cannabis Use among Patients with Inflammatory Bowel Disease (IBD).International journal of environmental research and public health · 2023
    Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Waseem AhmedDr Ahmed is an internal medicine resident at the New York University Medical Center in New York, New York. Dr Katz is a clinical professor in the Division of Gastroenterology at the New York University Medical Center and an associate director of the Inflammatory Bowel Disease Program at the Tisch Hospital and Ambulatory Care Center in New York, New York.
Seymour KatzDr Ahmed is an internal medicine resident at the New York University Medical Center in New York, New York. Dr Katz is a clinical professor in the Division of Gastroenterology at the New York University Medical Center and an associate director of the Inflammatory Bowel Disease Program at the Tisch Hospital and Ambulatory Care Center in New York, New York.
Tisch Hospital · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The marijuana plant

Indexed as

cannabisCrohn’s diseaseInflammatory bowel diseaseulcerative colitis

Identifiers

PMID28035196
PMCPMC5193087
OpenAlexW2974515265

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.